Loading...
Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer
Four decades ago, angiogenesis was recognized as a therapeutic target for blocking cancer growth. Because of its importance, VEGF has been at the center stage of antiangiogenic therapy. Now, several years after FDA approval of an anti-VEGF antibody as the first antiangiogenic agent, many patients wi...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
American Society for Clinical Investigation
2013
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3726176/ https://ncbi.nlm.nih.gov/pubmed/23908119 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI70212 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|